Stock data

順藥 (6535)

順藥 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$0.21M, down 95.1% from a year earlier. EPS over the last four quarters totals -NT$2.23.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 順藥 in Insightr